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1. Introduction
　Invasion and metastasis are characteristic features of 
malignant tumors.  Although the molecular mechanisms 
underlying metastasis are complex, it is clear that me-
tastasis requires a cascade of sequential steps that in-
volves the coordination of adhesion, motility, and 
growth1.  After tumor cells intravasate into the blood-
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Abstract : Adenoid cystic carcinoma（AdCC）is characterized by frequent recurrence and distant metastasis.  
Although lung metastasis in AdCC is very common, the mechanism by which this occurs is uncertain.  When 
ﬁ ve AdCC cell lines（ACCS, ACCT, ACCH, Acc-3, and Acc-M）were screened for metastatic ability by inject-
ing tumor cells into nude mice via the tail vein, lung metastases were found in mice injected with Acc-M（15/16 
mice）but not in mice injected with any of the other four cell lines（0/10 mice with each line）.  To determine 
why Acc-M metastasizes to the lung but the others do not, we examined the biological characteristics of Acc-M 
and compared them with those of the other lines. 
　Nuclear factor-κB（NF-κB）may play a key role in malignant tumor behaviors such as invasion and me-
tastasis.  Thus, we examined these cell lines for response to tumor necrosis factor（TNF-α）, one of the typical 
stimulators of NF-κB.  Although treatment with TNF-α stimulated matrix metalloprotease 9（MMP-9）ex-
pression in all cell lines, the response to TNF-α varied between cell lines ; the greatest stimulation was ob-
served in Acc-M.  Acc-M expressed higher levels of TNF receptors（both TNF-R1 and TNF-R2）than did the 
other AdCC lines.  Judging from inhibitor-κBα degradation and nuclear translocation and DNA binding by 
NF-κB, the degree of activation of NF-κB in response to TNF-α in Acc-M cell lines was very high compared to 
the other lines. Moreover, the ability of Acc-M cells to adhere to endothelial cells, which was greater than that 
of the other cell lines, was further enhanced by pretreatment with TNF-α.  Acc-M cells also expressed higher 
levels of sialyl Lewisx than did the other AdCC cell lines.  These ﬁ ndings suggest that lung metastasis is medi-
ated by tumor-endothelial cell interaction, which is probably associated with the NF-κB activation pathway.  
Further experiments are required to identify the molecules that mediate both lung metastasis and NF-κB ac-
tivation.
Key words : lung metastasis, NF-κB, adenoid cystic carcinoma, adhesion molecules
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stream they evade innate immune surveillance, adhere 
to vascular endothelial cells of distant organs, and ex-
travasate into such tissues.  After extravasation, the tu-
mor cells settle in the parenchyma of target organs and 
create metastatic deposits2.  
　Nuclear factor κB（NF-κB）plays a key role in ma-
lignant tumor behaviors, including invasion and metas-
tasis.  NF-κB is a transcription factor that induces the 
expression of various genes, leading to inﬂ ammatory re-
actions, embryonic morphogenesis, and antiapoptosis3-5. 
The typical stimulators of NF-κB, such as tumor necro-
sis factor α（TNF-α）and interleukin 1（IL-1）, activate 
the IκB kinase（IKK）complex, which contains IKKα, 
IKΚβ, IKKγ, and IKK complex-associated protein, 
through TNF receptor-associated factors（TRAFs）.  An 
inhibitor of NF-κB, known as IκB, which binds and 
holds NF-κB in the cytoplasm, can be phosphorylated 
by IKKα and IKΚβ.  The phosphorylated IκB is then 
ubiquitinated by ubiquitin ligase and degraded by 26S 
proteasomes. Freed NF-κB, which is a heterodimer of 
the p65 and p50 subunits, translocates from the cyto-
plasm into the nucleus and binds to a speciﬁ c sequence 
in the promoter of target genes.   
　We previously reported that activation of NF-κB 
stimulates motility and matrix metalloprotease 9
（MMP-9）and urokinase-type plasminogen activator
（uPA）expression by cultured squamous cell carcinoma
（SCC）cells6.  Pretreatment of these cells with synthet-
ic proteasome inhibitors or dexamethasone suppresses 
cell migration and MMP-9 and uPA expression, suggest-
ing that a shutoff of NF-κB signaling results in inhibi-
tion of tumor invasion.
　Adenoid cystic carcinoma（AdCC）is the most com-
mon malignant tumor of the salivary gland.  AdCC 
grows slowly but spreads relentlessly into adjacent tis-
sues ; recurrence of AdCC is common and distant metas-
tasis, especially to the lungs, is very frequent7.  AdCC is 
histologically characterized by a cylindrical or cystic 
stroma that is surrounded by anastomosing cords of epi-
thelial tumor cells.  The cystic stroma, as well as the 
other interstitium surrounding the tumor islands, is of-
ten hyalinized and contains various substances, includ-
ing collagen-like fibers, elastin, basement membrane 
materials, and mucopolysaccharides7.  We previously 
demonstrated that two cell lines derived from AdCC are 
able to form pseudocysts and produce large amounts of 
extracellular matrix（ECM）in vitro8.  AdCC cells can 
degrade considerable amounts of mesenchymal-elabo-
rated ECM, mainly via the uPA-plasmin cascade9. 
Moreover, the migration responses of AdCC cell lines to 
the ECM, especially type IV collagen, are strong and 
this may be due to overexpression of uPAR, which plays 
a key role in focal adhesion assembly and migration10-11.
　In this study we focus on the mechanism of lung me-
tastasis of AdCC cells.  An AdCC cell line, Acc-M, pos-
sessing high metastatic activity, was found to show dif-
ferent phenotypes from the other AdCC cell lines and 
high NF-κB activation in response to TNF-α. 
2. Materials and Methods
1）Cells and culture
　This study examined five human AdCC cell lines : 
ACCS8-11 ; ACCT and ACCH, which were established in 
our laboratory; and Acc-312 and Acc-M13, which were es-
tablished in Shanghai Second Medical University. 
These AdCC cell lines were maintained in Dulbecco's 
modified Eagle's medium（DMEM ; Sigma-Aldrich）
supplemented with 10% fetal bovine serum（FBS ; Fil-
ton Pty Ltd, Brooklyn, Australia）and 2 mM L-gluta-
mine in a 5% CO2 incubator at 37℃ .  Human umbilical 
venous endothelial cells（HUVECs; kindly provided by 
the Department of Clinical Pharmacology, Graduate 
School of Medical Science, Kyushu University）were 
maintained in low-glucose DMEM supplemented with 
20% FBS and 0.1 mg/ml basic-ﬁ broblast growth factor 
in a 5% CO2 incubator at 37℃ . 
2）Reagents and antibodies 
　Rabbit polyclonal antibodies to human NF-κB p65
（RelA）and IκBα were purchased from Santa Cruz 
Biotechnology（Santa Cruz, CA）.  Mouse monoclonal 
antibodies（mAbs）to human TNF receptor（TNF-R1, 
TNF-R2）were obtained from HyCult Biotechnology
（Uden, Netherlands）.  Rabbit polyclonal antibodies to 
human MMP-9 were purchased from Calbiochem（Cam-
bridge, MA）. Recombinant human TNF-α was kindly 
provided by Dainippon Pharmaceuticals（Tokyo, Ja-
pan）.  
　Mouse mAb to uPAR（3937）was obtained from 
American Diagnostics, Inc.（Greenwich, CT）.  Anti-α1 
integrin mAb（MAB 1973）, anti-α3 integrin mAb（MAB 
2056）, anti-α4 integrin mAb（MAB 1383）, anti-α5 inte-
grin mAb（CBL 497）, anti-αV integrin mAb（MAB 
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1953）, anti-β1 integrin mAb（MAB 2247）, and mouse 
mAb to human sialyl Lewisa were all purchased from 
Chemicon International, Inc.（Temecula, CA）.  Anti-α2 
integrin mAb（SC-13546）and anti-α6 integrin mAb
（SC-13542）were purchased from Santa Cruz Biotech-
nology.  Mouse mAb to human sialyl Lewisx was pur-
chased from Seikagaku Corporation（Tokyo, Japan）. 
FITC-conjugated goat anti-mouse or -rabbit IgG were 
obtained from Biosource International（Camarillo, 
CA）. 
3）Flow cytometric（FCM）analysis
　FCM was used to detect cell surface levels of various 
proteins, such as integrins, TNF-α receptors, uPAR, 
and sialyl Lewis, as described previously14.  Cells were 
harvested in phosphate-buffered saline（PBS）contain-
ing 0.025% trypsin and 0.01% EDTA and re-suspended 
in DMEM following centrifugation.  After washing with 
ice-cold PBS, 1 × 106 cells were incubated in 100μl of 
primary antibody or non-immune serum on ice for 30 
min, washed in ice-cold PBS, and then incubated in 100 
μl of FITC-conjugated second antibody on ice for 30 
min.  Labeled cells were analyzed in a FACSort cytome-
ter（Becton Dickinson Immunocytometry Systems, San 
Jose, CA）at the same settings for all analyses.  Imme-
diately before analysis, 20 to 40 μg/ml of propidium io-
dide was added to the cells to allow dead cells to gate 
out.
4）Animals and metastasis assay   
　Eight-week-old female athymic nude mice（BALBc 
cAJcl-nu）were purchased from Kyudo（Fukuoka, Ja-
pan）.  The mice were housed in laminar ﬂ ow cabinets 
under speciﬁ c pathogen-free conditions in facilities ap-
proved by Kyushu University.  For the experimental 
lung metastasis studies, 1× 106 cells were injected via 
the tail vein.  Eight weeks after injection, the mice were 
sacrificed and the lungs recovered.  If metastatic foci 
could be seen with the naked eye, the foci were counted.
5）Immunoﬂ uorescence staining
　Cellular localization of NF-κB p65 was analyzed 
using indirect immunoﬂ uorescence staining.  AdCC cells 
grown on glass cover slips were treated with or without 
TNF-α（10 ng/ml）for 15 min, fixed in 2% parafor-
maldehyde and permeabilized in PBS, 0.1 M glycine, 
and 0.05% Triton X-100.  After blocking with 1% bovine 
serum albumin（BSA）, rabbit anti-human NF-κB 
p65 polyclonal antibody was applied to the cultures, 
followed by incubation for 1 h at room temperature. 
After three 10-min washed in PBS, the samples were 
incubated for 1 h at room temperature in the presence 
of FITC-conjugated goat anti-rabbit IgG.  After sub-
sequent washes, the images were captured using a CCD 
camera and subsequently processed for analysis using 
CoolSnap software（Roper Scientiﬁ c, Trenton, NJ）.
6）Western blot analysis  
　For MMP-9 and IκBα detection, the whole-cell pro-
teins were separated on a 12.5% SDS-polyacrylamide 
gel and transferred electrophoretically onto nitrocellu-
lose membranes（Bio Rad Laboratories, CA）.  After 
blocking with 5% skimmed milk in Tris-buffered saline 
containing 0.1% Tween 20（TBS-T）, the membranes 
were incubated with primary antibody at 4℃ overnight, 
then incubated with horseradish peroxidase-conjugated 
secondary antibody（DAKO, Carpinteria, CA）for 1 h. 
The bound antibodies were visualized using ECL West-
ern blotting detection reagents（Amersham Pharmacia 
Biotech, UK）.
7）Zymography  
　Zymography was performed as described previously14. 
Serum-free conditioned medium was collected from a 
confluent culture of AdCC cells incubated in the pres-
ence of reagents for 24 h.  The conditioned media were 
resolved by 10% sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis（SDS-PAGE）in the presence of 1 
mg/ml gelatin.  The amounts of each medium applied to 
the gel were standardized to the total protein levels of 
cultured cells.  The resulting gel was washed in 10 mM 
Tris（pH 8.0）containing 2.5% Triton X-100 and was 
then incubated for 16 h in reaction buffer（50 mM Tris
（pH 8.0）, 0.5 mM CaCl2, 10－6 M ZnCl2）at 37℃.  After 
staining with Coomassie brilliant blue R-250, gelatinas-
es were identiﬁ ed as clear bands of lysis against a blue 
background.
8）Electrophoretic mobility shift assay（EMSA）
　Nuclear extracts were prepared using“NE-PERTM 
Nuclear and Cytoplasmic Extraction Reagents”（Pierce 
Chemical Co., IL, USA）according to the manu fac-
turer's instructions.  The DNA binding reaction was 
performed with a biotin end-labeled NF-κB oligo-
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nucleotide（5'-AGCTTGGGGACTTTCCGAG-3'）using 
the“LightShiftTM Chemiluminescent EMSA kit”（Pierce 
Chemical Co.）.  Biotin end-labeled NF-κB oligo nuc-
leotide was incubated with the nuclear extracts for 
20 min at room temperature.  After the reaction, the 
DNA-protein complexes were subjected to a 6% native 
polyacrylamide gel electrophoresis and transferred to 
a nylon membrane（Byodyne B membrane ; Pierce 
Chemical Co.）.  The biotin end-labeled DNA was de-
tected using a streptavidin-horseradish peroxidase 
conjugate and a chemiluminescent substrate according 
to the manufacture's instructions.
9）Cell adhesion assay
　To quantify tumor cell adhesion to HUVECs, a stan-
dard static adhesion assay was developed from the pro-
cedure of Miranda et al.15.  HUVECs（1.5 × 104 cells）
were placed in a 96-well microtiter plate precoated with 
0.1% gelatin（Sigma）and cultured in low-glucose 
DMEM with 20% FCS and 0.1 μg/ml basic-FGF for 2-3 
days to establish conﬂ uent HUVECs monolayers.  Prior 
to the adhesion assay, the endothelial monolayers were 
incubated with 10 ng/ml TNF-α or vehicle for 12 h. 
AdCC cells（4 × 104 cells/well）were added to the en-
dothelial monolayer and allowed to adhere at 37℃ for 
30 min.  The wells were washed three times with PBS 
and fixed with methanol for 15 min at room tempera-
ture.  The adherent cells were quantified by light mi-
croscopy under a high power ﬁ eld（× 200）.  For each of 
the triplicate experiments, the number of cells in five 
randomly chosen ﬁ elds was determined and the counts 
were averaged. In some experiments, tumor cells were 
also treated with 10 ng/ml TNF-α for 12 h before the 
adhesion assay.
3. Results and Discussion
　Cell lines established from AdCC may serve as useful 
tools for understanding the biology of this type of tumor. 
We have studied the biological characteristics of this pe-
culiar tumor, using mainly the ACCS cell line.  AdCC is 
characterized by vigorous production and accumulation 
of a large amount of ECM, including basement mem-
brane components.  In vitro, as in vivo, AdCC-derived 
cell lines, such ACCS, produce a large amount of ECM, 
including collagen, elastin, basal lamina components, 
and mucopolysaccharides8.  ACCS cells also produce a 
significant amount of proteolytic enzymes, including 
uPA, MMP-2, and MMP-9, and can degrade consider-
able amounts of mesenchymal-elaborated ECM, mainly 
via the uPA-plasmin cascade9.  However, ECM produced 
by ACCS cells themselves is resistant to degradation by 
ACCS cells, because it contains plasminogen activator 
inhibitor type 1（PAI-1）.  These ECM components may 
accumulate in the intercellular spaces, resulting in the 
formation of a pseudocyst, which is the characteristic 
architecture of AdCC8.  Consequently, the AdCC cells 
may become surrounded by their own ECM as well as 
by normal host connective tissue.  AdCC spreads relent-
lessly into adjacent tissues and shows a special proclivi-
ty for invading nerves and endothelial sheaths7-8，16. 
The frequencies of recurrence and distant metastasis of 
AdCC are very high.  We have also suggested that AdCC 
cells might initially proliferate along the tumor-pro-
duced ECM containing basement membrane compo-
nents.  In fact, the migration responses of ACCS and 
ACCT cell lines to the ECM, especially type IV or type I 
collagen, are significantly stronger than those of oral 
SCC cell lines10-11.  
1）Metastasis to lungs
　The above data on ACCS and ACCT may well demon-
strate tumor behavior, including migration and invasion 
into adjacent tissues, nerves, and endothelial sheaths. 
However, from these data we could not identify the 
mechanism of distant metastasis, which is very common 
in this tumor type.  In contrast to oral SCCs, which me-
tastasize lymphatically, AdCCs often show blood-borne 
metastasis and in most cases metastasize to the lungs. 
To examine the proclivity of AdCC for metastasis to the 
lungs, we screened ﬁ ve AdCC cell lines（ACCS, ACCT, 
ACCH, Acc-3, and Acc-M）for metastatic ability by in-
jecting tumor cells into nude mice via the tail vein. 
Eight weeks after intravenous injection with 1 × 106 
cells, the mice were sacrificed and all organs were ex-
amined for the presence of metastatic foci.  Of 16 mice 
injected with Acc-M, 15 had a large number of tumor 
nodules（average± SD ; 46.8 ± 24.2）in the lungs but 
not in other organs（Table 1）.  Such metastatic masses 
were not detectable in any mice injected with ACCS, 
ACCT, ACCH, and Acc-3（each line was injected into 10 
mice）.  
2）Integrin expression
　To identify the mechanism by which Acc-M, unlike 
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the other cell lines, metastasizes to the lungs, we com-
pared the phenotype of Acc-M to the other lines.  Cell 
surface integrin expression is important for cell adhe-
sion and migration.  Flow cytometry provides a relative 
measure of cell surface integrin levels. We have report-
ed that most AdCC cell lines show levels of integrin 
subunit expression similar to those of oral SCC lines, 
although the migration responses of ACCS and ACCT 
cell lines to the ECM, especially type IV or type I colla-
gen, are significantly stronger than those of oral SCC 
cell lines10-11.  The enhanced migration of these AdCC 
cells to collagens was significantly and exclusively in-
hibited by anti-α2 integrin antibodies.  ACCS, ACCT, 
and ACCH expressed signiﬁ cant levels of α2, α3, and α6 
integrin but not α1 or α4.  These three cell lines ex-
pressed very high surface levels of uPAR.  We previously 
demonstrated that numerous focal adhesions consisting 
of uPAR, vinculin, and paxillin were assembled when 
ACCS or ACCT cells were plated on collagen11.  Using 
an ACCS-AS cell line transfected with a vector express-
ing antisense uPAR RNA, we suggested that AdCC has 
a proclivity for migrating to type I and IV collagens ow-
ing to the overexpression of uPAR, which plays a key 
role in focal adhesion assembly and migration11.  Acc-M 
and Acc-3 had elevated levels of β1 and α5 integrin and 
lower levels of α2, α3, and α6 integrin as compared to 
ACCS, ACCT, and ACCH（Fig. 1）.  Correlated with in-
tegrin expression, the adhesion of Acc-M and Acc-3 cells 
to fibronectin was considerably higher（not shown）, 
while the other three lines showed a high ability to ad-
here to collagen10.  The similar expression of the β1 
integrin family on Acc-M and non-metasatic Acc-3 sug-
gests that there is no association between lung metasta-
sis and integrin expression.  Neither Acc-M nor Acc-3 
overexpressed uPAR（Fig. 1）.
Fig. 1　Expression of integrins and uPAR on different cells. Cells were 
stained with the indicated anti-integrin or anti-uPAR antibodies 
or secondary antibody alone and analyzed by ﬂ ow cytometry. All 
cell lines gave a single peak of ﬂ uorescence intensity for each in-
tegrin. The mean ﬂ uorescence values（arbitrary units）were cal-
culated by subtracting the mean ﬂ uorescence of the peak for sec-
ondary antibody-labeled cells from the mean ﬂ uorescence of the 

















Frequency of lung metastasis in athymic nude mice intrave-
nously injected with tumor cells. Cells（1×106 cells）of the 
indicated lines were inoculated into each mouse via the tail 
vein. Eight weeks after injection, the mice were sacrificed 
and the lungs were recovered. If metastatic foci could be 
seen with the naked eye, the foci were counted.
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3）NF-κB activation
　NF-κB may play a key role in malignant tumor be-
haviors, including invasion and metastasis.  We have 
previously reported that one of the typical stimulators 
of NF-κB, TNF-α, induces the activation of NF-κB, 
which stimulates motility and the expression of MMP-9 
and uPA in cultured SCC cells6.  Acc-M cells express 
very low or negligible levels of MMP-9, while the other 
AdCC lines spontaneously produce large amounts of 
MMP-9, even in the absence of TNF-α. Treatment with 
TNF-α（10 ng/ml）resulted in an increase in MMP-9 
production in all cell lines, but its enhancement varied ; 
very strong enhancement was observed in Acc-M cells
（Fig. 2）.  Various AdCC cell lines were tested for TNF-
induced NF-κB activation.  Cells treated with TNF-α
（10 ng/ml）for 15 min exhibited nuclear translocation 
of p65（RelA）（immunocytochemistry, Fig. 3A）, IκBα 
degradation（Western blot, Fig. 3B）, and DNA-NF-κB 
binding（electrophoretic mobility shift assay, EMSA, 
Fig. 3C）.  In all assays TNF-α rapidly induced NF-κB 
activation in Acc-M cells ; it induced IκBα degradation 
and nuclear translocation and DNA binding of NF-κB. 
The other lines showed a mild activation of NF-κB in 
response to TNF-α.  The high level of NF-κB activation 
in response to TNF-α in Acc-M cells may be owing to 
cell surface levels of TNF-Rs.  Analysis with ﬂ ow cytom-
etry demonstrated that both TNF-R1 and TNF-R2 are 
higher in Acc-M than the other AdCC lines（Fig. 4）.
4）Adhesion to endothelial cells
　The molecular mechanisms underlying metastasis are 
complex and involve multi-step processes.  The metas-
tasis experiments aim to model the events that occur af-
ter tumor cells intravasate into the bloodstream.  The 
tumor cells must adhere to vascular endothelial cells of 
the lungs and extravasate into these tissues.  To eluci-
date the interaction between tumor cells and vascular 
endothelial cells, an adhesion assay was performed us-
ing HUVECs.  Cell adhesion to endothelial cells was ex-
amined 30 min after plating onto a monolayer of HU-
VECs.  Although the adhesion ability of each AdCC cell 
line varied, the adhesion of Acc-M cells to HUVECs was 
greater than that of the other cell lines（Fig. 5）.  It is 
known that the interaction between tumor cells and 
vascular endothelial cells is mediated through adhesion 
molecules, including E- and P-selectins.  Like neutro-
phils, tumor cells are known to express some glycopro-
tein ligands for E- and/or P- selectins.  We previously 
reported that the expression of sialyl Lewisa, but not si-
alyl Lewisx, of oral SCC primary tumors significantly 
correlated with lymph metastasis17.  In a variety of car-
cinomas, moreover, sialyl Lewisa or sialyl Lewisx expres-
sion has been reported to correlate with hematogenous 
metastasis18-22.  Acc-M cells expressed higher levels of 
sialyl Lewisx, but not sialyl Lewisa, than did the other 
AdCC cell lines（Fig. 6）.  The adhesion of Acc-M cells to 
HUVECs increased when HUVECs or tumor cells were 
pretreated with TNF-α（Fig. 7A）.  Unstimulated endo-
Fig. 2　Effect of TNF-α on MMP-9 production. AdCC cells were cultured to subconﬂ u-
ency and treated with 10 ng/ml of TNF-α（＋）or vehicle（－）for 24 h. The 
resulting conditioned media were subjected to gelatin zymography（A）and 
immunoblotting with anti-MMP-9（B）. 
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thelial cells express no or little E- or/and P-selectins, 
and these molecules are induced by inflammatory 
cytokines, such as TNF-α and IL-123-24.  In the present 
study, treatment with TNF-α resulted in an increase in 
expression of E-selectin but not P-selectin on HUVECs
（Fig. 7B）and did not enhance the expression of sialyl 
Lewisx or sialyl Lewisa on tumor cell lines（data not 
shown）.  Therefore, we cannot explain why adhesion of 
Acc-M cells to HUVECs was enhanced by pretreatment 
of the tumor cells with TNF-α.  Recent studies have 
demonstrated that several novel sialomucins bind E- or/
and P-selectins.  Further experiments are required to 
identify the molecules that mediate adhesion between 
Acc-M cells and endothelial cells and which probably 
mediate lung metastasis and NF-κB activation.  
Fig. 3　TNF-α-induced NF-κB activation in different AdCC cell lines.  Each cell line 
was stimulated with 10 ng/ml of TNF-α（＋）or vehicle（－）for 15 min. After 
that, nuclear translocation of p65 was examined immunohistochemically（A）, 
the whole cell was analyzed for the presence of IκBα by Western blotting（B）, 
or the nuclear extracts prepared from the cells were assayed for DNA-NF-κB-
binding activity by EMSAs.
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Fig. 4　Expression of TNF receptors（TNF-Rs）on differ-
ent cells. The cell surface levels of TNF-R1 and 
TNF-R2 were analyzed and calculated by ﬂ ow cy-
tometry as described in the legend of Fig. 1.
Fig. 5　Comparison of the adhesion of different AdCC cell 
lines with endothelial cells（HUVECs）. AdCC 
cells（4× 104 cells/well）were added to the TNF-
α-treated（＋）or untreated（－）endothelial 
monolayers and allowed to adhere at 37℃ for 30 
min. The wells were washed three times with PBS 
and ﬁ xed with methanol for 15 min at room tem-
perature. Adherent cells were quantiﬁ ed by light 
microscopy under a high power ﬁ eld（× 200）. All 
the experiments were performed in triplicate and 
repeated at least three times. Error bars repre-
sent the standard deviations of the ratios calcu-
lated in separate experiments. 
Fig. 6　Comparison of expression of sialyl Lewisx/a on dif-
ferent AdCC cell lines. The cell surface levels of 
sialyl Lewisx（sLex）and sialyl Lewisa（sLea）
were analyzed and calculated by flow cytometry 
as described in the legend of Fig. 1.
Fig. 7　Effect of TNF-α on the adhesion of Acc-M cells to endothelial cells（A）and selectin expression on endotheli-
al cells（B）. In A, Acc-M cells were treated with 10 ng/ml of TNF-α（＋）or vehicle（－）and then 4× 104 
cells/well were added to the TNF-α-treated（＋）or untreated（－）HUVECs monolayer and allowed to ad-
here at 37℃ for 30 min. The wells were washed three times with PBS and ﬁ xed with methanol for 15 min at 
room temperature. The adherent cells were quantiﬁ ed by light microscopy under a high power ﬁ eld（×200）. 
All the experiments were performed in triplicate and repeated at least three times. Error bars represent the 
standard deviations of the ratios calculated in separate experiments. In B, HUVECs were stimulated with 
10 ng/ml of TNF-α（＋）or vehicle（－）and then the cell surface levels of E- and P-selectins were analyzed 
and calculated by ﬂ ow cytometry as described in the legend of Fig. 1.
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